
Inotrem
Developer of novel therapeutics designed to treat inflammatory diseases. The company's therapeutics focus on targeted immunotherapy for acute and chronic inflammatory syndromes and have strong experti...
Valuation
$0
Share Price
N/A
Total Raised
$135.9M
Last Round
N/A